SCHEMBL6336249

SCHEMBL6336249

COc1c(Cl)cc(C(C)=O)c(O)c1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 2/20 0.42
HTT P42858 2/20 0.40
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 4/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
TAS1R3 Q7RTX0 3/20 0.37
TAS1R1 Q7RTX1 3/20 0.37
TAS1R2 Q8TE23 3/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ABCB11 O95342 1/20 0.36
HSD17B10 Q99714 1/20 0.35
HSP90AA1 P07900 1/20 0.35
NSD2 O96028 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798411 0.84 TPMT (0.46) TPMTHTTALDH1A1KDM4EGAA
SCHEMBL24106350 0.83 TPMT (0.45) TPMTHTTALDH1A1KDM4EHPGD
SCHEMBL31632326 0.80 TPMT (0.42) TPMTHTTALDH1A1KDM4EGAA
SCHEMBL9929207 0.79 HPGD (0.38) HTTALDH1A1KDM4EHPGDCYP3A4
SCHEMBL9938269 0.78 TPMT (0.42) TPMTHTTALDH1A1KDM4EGAA
SCHEMBL9928852 0.78 ABCB11 (0.37) TPMTHTTALDH1A1KDM4EGAA
SCHEMBL9928731 0.77 MEN1 (0.37) HTTALDH1A1KDM4EHPGDCYP3A4
SCHEMBL9928807 0.77 IMPDH2 (0.39) TPMTHTTALDH1A1KDM4EGAA
SCHEMBL9928958 0.76 MEN1 (0.36) HTTALDH1A1KDM4EHPGDMAPK1
SCHEMBL9928742 0.75 LMNA (0.36) TPMTHTTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABOTT LABORATORIES 2005-09-22 US disclosed
US-20050187387-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R TPMT 3229/4885HTT 119/4885ALDH1A1 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.